Paul Knight
Stock Analyst at Keybanc
(2.39)
# 2,544
Out of 4,966 analysts
135
Total ratings
47.32%
Success rate
-1.92%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Upgrades: Overweight | $15 | $8.86 | +69.30% | 9 | Aug 6, 2025 | |
| XGN Exagen | Upgrades: Overweight | $17 | $9.86 | +72.41% | 6 | Jul 30, 2025 | |
| EHC Encompass Health | Maintains: Overweight | $122 → $135 | $121.76 | +10.87% | 1 | May 27, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.50 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $54.63 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $301.80 | +52.42% | 5 | Mar 31, 2025 | |
| LAB Standard BioTools | Downgrades: Sector Weight | n/a | $1.26 | - | 2 | Feb 27, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $470 → $325 | $246.95 | +31.61% | 11 | Feb 14, 2025 | |
| RPID Rapid Micro Biosystems | Initiates: Overweight | $8 | $2.41 | +231.95% | 1 | Feb 12, 2025 | |
| RVTY Revvity | Maintains: Overweight | $132 → $145 | $90.11 | +60.91% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $202.20 | +107.72% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $119.63 | +92.26% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $25.05 | +31.74% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $24.01 | +49.94% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $205.82 | +50.62% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $122.32 | +79.86% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $492.72 | - | 6 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $23.01 | +60.80% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $2.42 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $4.32 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $125.66 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $30.54 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $13.47 | +196.96% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $163.31 | +83.70% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $190.81 | +31.02% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $126.41 | +248.86% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $127.66 | +84.87% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $67.40 | +46.90% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $11.94 | +360.64% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $30.34 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $67.64 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $99.96 | - | 5 | Oct 23, 2017 |
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $8.86
Upside: +69.30%
Exagen
Jul 30, 2025
Upgrades: Overweight
Price Target: $17
Current: $9.86
Upside: +72.41%
Encompass Health
May 27, 2025
Maintains: Overweight
Price Target: $122 → $135
Current: $121.76
Upside: +10.87%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.50
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $54.63
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $301.80
Upside: +52.42%
Standard BioTools
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.26
Upside: -
West Pharmaceutical Services
Feb 14, 2025
Maintains: Overweight
Price Target: $470 → $325
Current: $246.95
Upside: +31.61%
Rapid Micro Biosystems
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $2.41
Upside: +231.95%
Revvity
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $90.11
Upside: +60.91%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $202.20
Upside: +107.72%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $119.63
Upside: +92.26%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $25.05
Upside: +31.74%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $24.01
Upside: +49.94%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $205.82
Upside: +50.62%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $122.32
Upside: +79.86%
Oct 26, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $492.72
Upside: -
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $23.01
Upside: +60.80%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $2.42
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $4.32
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $125.66
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $30.54
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $13.47
Upside: +196.96%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $163.31
Upside: +83.70%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $190.81
Upside: +31.02%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $126.41
Upside: +248.86%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $127.66
Upside: +84.87%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $67.40
Upside: +46.90%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $11.94
Upside: +360.64%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $30.34
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $67.64
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $99.96
Upside: -